Vendor, Miami, FL
Ridgeback Biotherapeutics LP
UEI J486UJLMAKB5, CAGE 8B1C9
2 awards and -$884,705 obligated between August 15, 2025 and June 10, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$884,705 |
Industries
NAICS on the awards, by dollars.
| Research and Development in NanotechnologyNAICS 541713 | -$884,705 |
How it wins
Awards by competition, set-aside and type.
| Not Competed | 2 |
| Definitive Contract | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50119C00059Definitive Contract, August 15, 2025, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Additional IN-SCOPE Work for CMC Efforts for MAB114 Development for the Treatment of Ebola.NAICS 541713, PSC AN13 | $0 |
| 75A50120C00009Definitive Contract, August 15, 2025, Not Competed, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | CMC Efforts for MAB114 for the Development and Treatment of Ebola.NAICS 541713, PSC AN13 | -$884,705 |
- Places of performance
- Florida
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 4 across 2 awards